对欧洲肝脏疾病的谷歌搜索趋势的评估
Andreas Teufel1, Timo Itzel2, Anca Zimmermann3
1Department of Medicine II, Section of Hepatology, Section of Clinical Bioinformatics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-Württemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. andreas.teufel@umm.de.
Journal of gastrointestinal and liver diseases : JGLD
|June 30, 2024
概括
公众对代谢功能障碍相关的脂肪性肝病 (MASLD) 的兴趣有所增长,但对其严重形式MASH的搜索有所下降. 在线搜索反映了公众对更简单,母语术语的偏好,而不是复杂的医学术语.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 数字健康数字健康
背景情况:
- 慢性肝病是全球主要的健康问题.
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 影响了超过三分之一的成年人,但缺乏公众意识.
- 有效的知识转移对于改善MASLD的预防和治疗至关重要.
研究的目的:
- 分析2004-2021年谷歌搜索肝病的趋势.
- 了解公众对肝病,特别是MASLD的知识和意识如何在线发展.
- 识别与肝脏健康相关的公共搜索行为模式.
主要方法:
- 利用谷歌趋势数据在七种语言和全球范围内进行与肝脏疾病相关的搜索.
- 分析了2004年至2021年间的搜索趋势.
- 使用R包gtrendsR进行数据分析.
主要成果:
- 对MASLD (以前的NAFLD) 的兴趣普遍增加,而对MASH (一种严重形式的MASLD) 的兴趣下降.
- 病毒性肝炎C的搜索量下降;病毒性肝炎B的搜索量保持稳定,重点是疫苗接种.
- 病毒性肝炎的最新医学进展并没有显著改变搜索行为.
- 用户更喜欢母语和更简单的术语 (例如"脂肪肝") 而不是复杂的医疗缩写 (例如NAFLD).
结论:
- 谷歌搜索趋势反映了肝病学在过去二十年的演变.
- 公共搜索主要由非专家驱动,并缓慢地采用新的科学发现.
- 关于MASLD的传播策略应与公众对母语和简化术语的偏好保持一致,以提高认识.
相关概念视频
Diseases of the Liver and Gallbladder
507
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
507
Ultrasound II: Endoscopic Ultrasound and FibroScan
95
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
95


